Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Imugen

Imugen
1988 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of clinical laboratory testing services. The company conducts research for tick-borne diseases such as testing of Lyme diseases.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • 315 Norwood Park South
  • Norwood, MA 02062
  • United States

+1 (781) 000-0000

Imugen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Imugen‘s full profile, request access.

Request full access to PitchBook

Imugen Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genova Diagnostics Private Equity-Backed Asheville, NC 000 0000 000000000
0000 000000000000 Corporation Salt Lake City, UT
000000 00000 Corporate Backed or Acquired Rome, Italy 000 000000&0
000000 Private Equity-Backed Palo Alto, CA 0 000000000000
000000 00000000 00 Private Equity-Backed Hangzhou, China 0000 000000000000
To view this company’s complete list of competitors, request access »

Imugen Executive Team (3)

Name Title Board
Seat
Contact
Info
Victor Berardi Chief Executive Officer & Senior Scientist
Patricia Devine MD Laboratory Medical Director, Assistant & Associate Director
Philip Molloy MD Medical Director